Published in Blood Weekly, June 14th, 2001
To see if the model predicts mortality in patients awaiting liver transplants, researchers at the University of Nebraska Medical Center, Omaha, followed 70 patients and used MELD to calculate risk scores.
MELD successfully separated patients into low- and high-risk groups; over 12 months,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.